The opening session of AAO 2026 featured a keynote speech discussing how artificial intelligence (AI) will play a part in health care.
Publication|Articles|July 20, 2026
Supplements and Featured Publications
- TONMYA® (cyclobenzaprine HCl sublingual tablets): An Innovative Approach to Fibromyalgia Management
TONMYA® (cyclobenzaprine HCl sublingual tablets): An Innovative Approach to Fibromyalgia Management
Listen
0:00 / 0:00
This Clinical Brief was sponsored by Tonix Medicines, Inc.
Advertisement
This clinical brief reviews the clinical and economic impact of fibromyalgia, examines limitations of existing treatment approaches, and introduces a new treatment option.
Advertisement
Related to this article
Incidence of diabetic macular edema and the need for glaucoma surgery were reduced after treatment with glucagon-like peptide-1 receptor agonists.
Medicaid expansion was associated with lower colorectal cancer mortality, with the largest reductions in Hispanic patients and stage IV disease.
TP53 mutations occurred in 3% of myeloproliferative neoplasms (MPNs) but 10% of myelofibrosis or blast-phase cohorts in a review of 11 cohort studies.
Amanda Velazquez, MD, discusses GLP-1 formulary strategies, overcoming prior authorization hurdles, and building scalable obesity care infrastructure.
Cepheid's Connie Savor, MD, MBA, explains where its 13-pathogen respiratory panel fits in diagnostic stewardship and antibiotic decisions.
Older adults on Medicare report the best access to care among 10 countries but more cost-related problems and higher out-of-pocket spending.
Two inSPire2026 posters detail how health system specialty pharmacy teams support patients with ATTR-CM.
Advertisement
Advertisement
Trending on AJMC
1
MASH Fibrosis, Not Resolution, Predicts Mortality: Zobair Younossi, MD
2
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
3
5 Things to Know if Retatrutide Is Classified as a Biologic
4
GLP-1s Have Protective Benefit Against DME, Glaucoma Surgery
5